http://www.prosource.net/product_det...a-007446768adc






"Revolutionary New Clinically-Proven Protein Matrix Promotes Dramatic Physique Enhancement!
The World's Ultimate Bio-Active Protein Technology Has Arrived



Introducing Vectron™, a truly innovative, first-of-its-kind supplemental protein that's going to truly change forever the way athletes add lean muscle and shed body fat.

That, of course, is an ambitious claim. But Vectron™, unlike any other protein in today's marketplace, has the clinical validation† to back it up. Vectron™ is powered by an elite new fractionated protein complex called Prolibra®. Its proprietary composition includes a specialized bioactive peptide matrix along with a special whey mineral complex designed to precisely target key mechanisms of body transformation. This revolutionary new protein source is, in fact, so potent and bioactive that it has been clinically proven to promote dramatic results in major clinical trials.


Clinical test subjects retain twice as much muscle with 79% fat loss, compared to control

In an independent, randomized, double-blind, 12-week clinical trial† commissioned by the makers of Prolibra® and published in the Journal of Nutrition and Metabolism, test subjects showed significant improvements in the ratio of lean mass to fat while taking just 24.4 grams of Prolibra® per day, compared to a control group taking a placebo. That's not a misprint. Subjects achieved these extraordinary results using less than 25 grams per day. That's how potent and effective this protein is. In contrast, literally hundreds of grams of standard proteins have not achieved such extraordinary results in any published data we've seen.

Prolibra's power in promoting lean mass retention is critical for any diet or exercise program because muscle is more metabolically active and may improve calorie expenditure, thus supporting further weight loss. Remarkably, the subjects taking Prolibra® retained twice as much lean muscle with 79% fat loss compared to the control group at 51% fat loss. Prolibra is highly exceptional in this regard as no other whey-derived system has been clinically proven to achieve this type of body composition improvement in a 12-week period (not to mention at such a modest daily dose). Remarkably, the Prolibra® group, using just 24.4 grams per day lost 6.1% fat, which is a powerful testament to the extraordinary potency of this remarkable supplement.

Prolibra is highly exceptional in this regard as no other whey-derived system has been clinically proven to achieve this type of body composition improvement in a 12-week period (not to mention at such a modest daily dose).
Additionally, Prolibra® appears to help maintain a healthy glycemic response by reducing post-prandial glycemia. In a study conducted by Glycemic Index Laboratories, participants experienced a statistically significant reduction of up to 37.8 glycemic index units when Prolibra® was added to a liquid meal. This mechanism of helping maintain already healthy levels of blood sugar in turn may assist appetite control and enhance weight loss.

Its remarkable power is supported by three separate clinical trials (two focusing on body composition, and one focusing on glycemic lowering power).

Clearly, Vectron™ represents the most revolutionary protein the bodybuilding world has ever seen. This is a bold statement but considering the level of compelling science behind this product, it is indeed well founded. Achieve the ultimate combination of muscle mass and high definition with this truly amazing nutritional breakthrough. With the introduction of Vectron™, the protein market is about to change forever!

Scientific References:

†A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study. Joy L Frestedt1, John L Zenk1, Michael A Kuskowski2, Loren S Ward*3 and Eric D Bastian3. Address: 1Minnesota Applied Research Center (MARC), Edina, MN, USA, 2Geriatric Research Education and Clinical Center (GRECC), Veterans Administration Medical Center, Minneapolis, MN, USA and 3Glanbia Research and Development Center, Twin Falls, ID, USA."